TELA (TELA Bio Corp) רווחיות מכירות לפי רווח גולמי

The gross profit margin reflects cost efficiency, with the final figure standing at 67.20. TELA Bio, Inc. (TELA) is expanding its OviTex biomatrix network, creating a high level of clinic dependency on its technologies. The automation of implant and mesh production minimizes defects by replacing manual labor. However, pressure from purchasing alliances limits pricing power, forcing the company to offer discounts.
פילוחי מדדים מקיפים ואנליטיקה עבור TELA Bio Corp (TELA)

Gross margin measures production efficiency by determining the portion of revenue remaining after direct product creation costs. By analyzing the gross margin history, an investor assesses the operational resilience of TELA Bio, Inc. (TELA) to rising costs, which is critical during disruptions in raw material supply chains for regenerative tissues and the narrowing of sales markets due to geopolitical sanctions.